Fig. 6From: Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trialsComparison of vomiting after study drug administration between DP and SP. RR Risk Ratio, CI Confidence Interval, DP Dihydroartemisinin-Piperaquine, SP Sulfadoxine- pyrimethamineBack to article page